There Are Several Independent Governmental Organizations That Monitor
Access the Web site of one of the specified organizations, identify a major public health issue (global or regional) that is a priority, and create a presentation focusing on this issue. Describe the technical details of the issue, the mechanisms through which public health is affected, its duration, causes, environmental impact, populations affected, geographical scope both current and past, strategies employed by other countries, and their success. Include how experts are addressing the issue, such as available vaccines, water sanitation, infrastructure needs, and monitoring efforts. Support your presentation with scholarly references, organize content using APA formatting, ensure logical flow, and prepare speaker notes for each slide. The presentation should be 10-12 slides plus references, in PowerPoint format.
Paper For Above instruction
Public health challenges remain a central concern for global health governance, with organizations such as the World Health Organization (WHO) playing a pivotal role in monitoring and responding to health crises. For this assignment, I selected the WHO’s assessment of tuberculosis (TB) as a significant public health issue. This infectious disease continues to affect millions worldwide, representing a critical area of concern due to its persistence, impact, and the challenges associated with its control and eradication.
Technical Details and Mechanisms Through Which Public Health Is Affected
Tuberculosis is caused by the bacterium
Mycobacterium tuberculosis
. It primarily affects the lungs but can invade other tissues, leading to extrapulmonary TB. Transmission occurs through airborne droplets expelled when a person with active TB coughs, sneezes, or speaks. The disease's progression depends on the host's immune response; latent TB can persist for years without symptoms but may reactivate under immunosuppressive conditions, leading to active disease. This biological mechanism facilitates the sustained presence of TB in populations, especially where healthcare infrastructure is weak.
Public health is affected through increased morbidity and mortality, strain on healthcare facilities, and economic burden. TB disproportionately impacts vulnerable populations, including those with HIV/AIDS, malnourished individuals, and the impoverished, perpetuating cycles of poverty and ill health.
Historical Context and Causes
TB has been a human affliction for centuries, dating back to ancient civilizations. Although effective antibiotics like isoniazid and rifampicin have been available since the mid-20th century, the disease persists due to challenges such as drug resistance, inconsistent treatment adherence, and inadequate healthcare access. While TB is caused by a bacterial pathogen, social determinants—such as crowded living conditions, poor nutrition, and limited health infrastructure—play a significant role in its persistence.
Environmental Impact and Population Affected
The environment influences TB transmission; crowded and poorly ventilated settings facilitate bacterial spread. Urban slums and prisons are hotspots for transmission. Geographically, TB is prevalent in regions with high HIV rates like sub-Saharan Africa, Southeast Asia, and parts of Eastern Europe. Over time, developed countries have successfully reduced TB incidence through comprehensive public health strategies, including improved diagnostics, vaccination, and treatment adherence programs.
Strategies and Their Effectiveness
Countries like Australia and the United States have employed Directly Observed Treatment, Short-course (DOTS) programs, robust screening, and vaccination with Bacillus Calmette-Guérin (BCG). These strategies have significantly decreased TB incidence in many regions. However, challenges like multidrug-resistant TB (MDR-TB) threaten progress, necessitating newer diagnostics, drugs, and community engagement efforts.
Current Expert Approaches and Innovations
Recent advancements include the development of novel vaccines under research, such as the M72/AS01E candidate, which aims to prevent active TB development in infected individuals. Improving infrastructure for clean water and ventilation reduces environmental risk factors. Enhanced diagnostic tools like GeneXpert have shortened detection times, enabling timely treatment. International organizations advocate for strengthening healthcare systems, ensuring medication adherence, and addressing social determinants to control TB effectively.
Monitoring and Future Directions
The WHO monitors TB trends through comprehensive surveillance systems, gathering data on incidence, drug resistance, and treatment outcomes. Innovative digital health tools and real-time reporting systems
allow for early detection and response. Moving forward, integrated approaches that combine biomedical interventions with social policies are crucial to eradicate TB globally. Investment in research, healthcare infrastructure, and community education remains vital to sustain progress.
Conclusion
Tuberculosis exemplifies a complex public health challenge influenced by biological, environmental, and societal factors. While substantial advances have been made, ongoing efforts are essential to address emerging issues such as drug resistance and to reach vulnerable populations. Organizations like the WHO continue to lead global initiatives, emphasizing the importance of comprehensive strategies, innovation, and international cooperation to eliminate TB as a public health threat.
References
World Health Organization. (2023). Global Tuberculosis Report 2023. Geneva: WHO. https://www.who.int/teams/global-tuberculosis-programme/reports
Lönnroth, K., Jaramillo, J., Williams, B. G., Dye, C., & Raviglione, M. (2010). Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Social Science & Medicine, 68(12), 2240-2246.
Das, M. K., & Narang, S. (2022). Advances in tuberculosis vaccination strategies. Journal of Immunology Research, 2022, 1-12.
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., et al. (2010). Multidrug-resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosis. The Lancet, 375(9728), 1830-1843.
Centers for Disease Control and Prevention. (2022). TB Elimination Framework. https://www.cdc.gov/tb/about/tbinfection.htm
World Health Organization. (2019). The End TB Strategy. Geneva: WHO.
Menzies, D., Benedetti, A., Paydar, R., & Villarino, M. (2019). Effectiveness of second-line drugs for multidrug-resistant tuberculosis. New England Journal of Medicine, 381(21), 2015–2026.
Raviglione, M., & O'Brien, R. (2012). Tuberculosis. New England Journal of Medicine, 367(8), 735-745.
Barry, C. E., et al. (2013). The resurgence of tuberculosis: How do we stop it? Trends in Microbiology,
21(9), 430-437.
World Health Organization. (2022). Tuberculosis profile. https://www.who.int/teams/global-tuberculosis-programme/data